Business Context and Reporting Period
This Form 8-K was filed by MIMEDX GROUP, INC. on February 21, 2019. The report addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance and listing status rather than financial performance data.
Material Changes
- Delisting Notification: Nasdaq notified the Company on February 21, 2019, of its intent to issue a press release on February 25, 2019, confirming the delisting of the Company's common stock.
- Reason for Delisting: The Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it is not current in filing its periodic reports.
- Appeal Status: The Company previously stated in an 8-K filed on November 7, 2018, that it did not intend to appeal the delisting determination.
- Process Timeline: Nasdaq intends to file a Form 25 with the SEC to effect the delisting. The delisting will become effective ten days after the Form 25 is filed.
Guidance, Outlook, and Risks
The filing contains no financial guidance or management commentary regarding future business operations. The primary risk disclosed is the imminent removal of the Company's common stock from Nasdaq trading, which will result in the stock trading on the OTC market or being suspended entirely pending further regulatory action.
Investor Verification Checklist
- Verify the exact date Nasdaq files Form 25 with the SEC to calculate the effective delisting date.
- Confirm the Company's current status regarding the filing of overdue periodic reports (10-K, 10-Q).
- Monitor for the press release scheduled for February 25, 2019, to confirm the official public announcement of delisting.
- Check if the Company has filed any subsequent 8-Ks regarding a potential appeal or alternative listing strategy.